Pre-emptive treatment with oral valganciclovir in management of CMV infection after cardiac transplantation
- 30 November 2004
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 23 (11) , 1277-1282
- https://doi.org/10.1016/j.healun.2003.08.034
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Prevention of Post-transplant Cardiovascular Disease – Report and Recommendations of an Ad Hoc GroupAmerican Journal of Transplantation, 2002
- New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant RecipientsClinical Microbiology Reviews, 2000
- Cytomegalovirus infection and cardiac allograft vasculopathyTransplant Infectious Disease, 1999
- GANCICLOVIR RESISTANCE AS A RESULT OF ORAL GANCICLOVIR IN A HEART TRANSPLANT RECIPIENT WITH MULTIPLE HUMAN CYTOMEGALOVIRUS STRAINS IN BLOOD1,2Transplantation, 1998
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998
- Editorial Response: Cytomegalovirus Disease and Allograft Loss After Organ TransplantationClinical Infectious Diseases, 1998
- CYTOMEGALOVIRUS PROPHYLAXIS WITH ANTIVIRAL AGENTS IN SOLID ORGAN TRANSPLANTATIONTransplantation, 1998
- LONG-TERM PROGNOSIS OF RENAL TRANSPLANTATION AFTER PREEMPTIVE TREATMENT OF CYTOMEGALOVIRUS INFECTIONTransplantation, 1997
- Infections in solid-organ transplant recipientsClinical Microbiology Reviews, 1997
- CLINICAL AND VIROLOGICAL MONITORING OF HUMAN CYTOMEGALOVTRUS INFECTION IN 294 HEART TRANSPLANT RECIPIENTSTransplantation, 1995